Your browser doesn't support javascript.
loading
Perceived helpfulness of bipolar disorder treatment: Findings from the World Health Organization World Mental Health Surveys.
Nierenberg, Andrew A; Harris, Meredith G; Kazdin, Alan E; Puac-Polanco, Victor; Sampson, Nancy; Vigo, Daniel V; Chiu, Wai Tat; Ziobrowski, Hannah N; Alonso, Jordi; Altwaijri, Yasmin; Borges, Guilherme; Bunting, Brendan; Caldas-de-Almeida, José Miguel; Haro, Josep Maria; Hu, Chi-Yi; Kiejna, Andrzej; Lee, Sing; McGrath, John J; Navarro-Mateu, Fernando; Posada-Villa, José; Scott, Kate M; Stagnaro, Juan C; Viana, Maria C; Kessler, Ronald C.
Afiliación
  • Nierenberg AA; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
  • Harris MG; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Kazdin AE; School of Public Health, The University of Queensland, Herston, QLD, Australia.
  • Puac-Polanco V; Queensland Centre for Mental Health Research, The Park Centre for Mental Health, QLD, Australia.
  • Sampson N; Department of Psychology, Yale University, New Haven, CT, USA.
  • Vigo DV; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Chiu WT; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Ziobrowski HN; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
  • Alonso J; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
  • Altwaijri Y; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Borges G; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Bunting B; Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Caldas-de-Almeida JM; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.
  • Haro JM; Pompeu Fabra University (UPF), Barcelona, Spain.
  • Hu CY; Epidemiology Section, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Kiejna A; National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
  • Lee S; School of Psychology, Ulster University, Londonderry, United Kingdom.
  • McGrath JJ; Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
  • Navarro-Mateu F; Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.
  • Posada-Villa J; Department of Psychology, College of Education, King Saud University, Riyadh, Saudi Arabia.
  • Scott KM; Shenzhen Institute of Mental Health & Shenzhen Kangning Hospital, Shenzhen, China.
  • Stagnaro JC; Psychology Research Unit for Public Health, WSB University, Torun, Poland.
  • Viana MC; Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.
  • Kessler RC; National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
Bipolar Disord ; 23(6): 565-583, 2021 09.
Article en En | MEDLINE | ID: mdl-33638300
OBJECTIVES: To examine patterns and predictors of perceived treatment helpfulness for mania/hypomania and associated depression in the WHO World Mental Health Surveys. METHODS: Face-to-face interviews with community samples across 15 countries found n = 2,178 who received lifetime mania/hypomania treatment and n = 624 with lifetime mania/hypomania who received lifetime major depression treatment. These respondents were asked whether treatment was ever helpful and, if so, the number of professionals seen before receiving helpful treatment. Patterns and predictors of treatment helpfulness were examined separately for mania/hypomania and depression. RESULTS: 63.1% (mania/hypomania) and 65.1% (depression) of patients reported ever receiving helpful treatment. However, only 24.5-22.5% were helped by the first professional seen, which means that the others needed to persist in help seeking after initial unhelpful treatments in order to find helpful treatment. Projections find only 22.9% (mania/hypomania) and 43.3% (depression) would persist through a series of unhelpful treatments but that the proportion helped would increase substantially if persistence increased. Few patient-level significant predictors of helpful treatment emerged and none consistently either across the two components (i.e., provider-level helpfulness and persistence after earlier unhelpful treatment) or for both mania/hypomania and depression. Although prevalence of treatment was higher in high-income than low/middle-income countries, proportional helpfulness among treated cases was nearly identical in the two groups of countries. CONCLUSIONS: Probability of patients with mania/hypomania and associated depression obtaining helpful treatment might increase substantially if persistence in help-seeking increased after initially unhelpful treatments, although this could require seeing numerous additional treatment providers. In addition to investigating reasons for initial treatments not being helpful, messages reinforcing the importance of persistence should be emphasized to patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar / Trastorno Depresivo Mayor Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Bipolar Disord Asunto de la revista: PSIQUIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Bipolar / Trastorno Depresivo Mayor Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Bipolar Disord Asunto de la revista: PSIQUIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Dinamarca